Bulletin
Investor Alert

Lineage Cell Therapeutics Inc.

ASE: LCTX

GO
/marketstate/country/us

Market closed

/zigman2/quotes/207994235/composite

$

0.92

Change

-0.05 -4.95%

Volume

Volume 661,529

Sep 23, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207994235/composite

Previous close

$ 0.97

$ 0.92

Change

-0.05 -4.95%

Day low

Day high

$0.91

$1.01

Open
Open: 0.96

52 week low

52 week high

$0.53

$1.67

Open

Market cap

$145.18M

Average volume

681,796

P/E ratio

N/A

Rev. per Employee

$17,924

EPS

-0.24

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lctx

MarketWatch News on LCTX

  1. BioTime started at buy with $3 stock price target at Maxim Group

    8:46 a.m. Jan. 24, 2019

    - Tomi Kilgore

  2. BioTime started at outperform with $6 stock price target at Raymond James

    8:15 a.m. March 31, 2017

    - Tomi Kilgore

  3. 13D Filings

    12:38 a.m. June 28, 2014

    - Barron's Online

  4. 13D Filings

    2:49 a.m. May 10, 2014

    - Barron's Online

  5. 13D Filings

    3:32 a.m. Jan. 4, 2014

    - Barron's Online

  6. BioTime offers equity stake for Geron assets

    9:46 a.m. Oct. 18, 2012

    - MarketWatch.com

  7. Osiris stem-cell therapy wins Canadian approval

    5:42 p.m. May 17, 2012

    - Val Brickates Kennedy

  8. Court upholds stem-cell research funding: reports

    11:45 a.m. July 27, 2011

    - Val Brickates Kennedy

  9. Are stem-cell stocks a good buy?

    3:05 p.m. July 13, 2011

    - Val Brickates Kennedy

  10. Endo, Celgene lead drug stocks lower

    4:53 p.m. Dec. 8, 2009

    - Val Brickates Kennedy

  11. BioTime Q2 revs $195,337 vs $97,297

    7:12 a.m. Aug. 13, 2004

    - Robert Daniel

  12. BioTime Q2 losses 2c vs 6c

    7:11 a.m. Aug. 13, 2004

    - Robert Daniel

  13. 13D Filings

    12:59 a.m. Feb. 24, 2004

    - Barron's Online

  14. BioTime plans rights offering

    9:15 a.m. Oct. 2, 2003

    - Greg Morcroft

  15. 13D Filings

    12:01 a.m. June 10, 2002

    - Barron's Online

  16. Winners and Sinners

    7:03 p.m. Oct. 20, 1997

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/lctx

Other News on LCTX

  1. Lineage Cell receives $24.6M payment; strong cash runway

    9:22 a.m. Aug. 31, 2020

    - Seeking Alpha

  2. Wall Street Breakfast: The Week Ahead

    7:40 a.m. Aug. 30, 2020

    - Seeking Alpha

  3. Stocks To Watch: Nvidia, Intel And Zoom Look To Dazzle

    8:00 a.m. Aug. 29, 2020

    - Seeking Alpha

  4. Seeking Alpha Catalyst Watch

    2:30 p.m. Aug. 28, 2020

    - Seeking Alpha

  5. 10-Q: LINEAGE CELL THERAPEUTICS, INC.

    4:25 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Stocks To Watch: Fireworks For Nikola, Tesla And Micron

    9:00 a.m. June 27, 2020

    - Seeking Alpha

  7. 10-Q: ONCOCYTE CORP

    4:44 p.m. May 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. 10-Q: LINEAGE CELL THERAPEUTICS, INC.

    4:41 p.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/lctx

Press Releases on LCTX

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.